Included support
- +Hospital matching
- +Record review
- +Care coordination
- +Travel support
- +Interpretation support

Cryoablation may be considered when the tumor is small, peripheral, and accessible by imaging, or when surgical risk is high and a minimally invasive approach is preferred. The decision combines tumor location and size, coagulation status, contralateral kidney function, and multidisciplinary assessm
24-72h
Response window
Approx. $3,100
Treatment fee
Peking Union Medical College Hospital - Beijing - Grade 3A
Ruijin Hospital - Shanghai - Grade 3A
West China Hospital - Chengdu - Grade 3A
Let us coordinate the treatment journey with you.
Suitable for small kidney tumors accessible by imaging, cryoablation involves percutaneous insertion of cryoprobes under CT or ultrasound guidance. The common practice is alternating freezing and thawing to form an ice ball covering the lesion, while monitoring adjacent structures. After the procedure, the probes are removed and pressure is applied for hemostasis. Postoperative observation focuses on bleeding, urine leakage, and pain, with the goal of ablating the lesion while preserving as much kidney tissue as possible. The above is general health information, not medical advice; specific details depend on specialist assessment and hospital protocols.
Suitable for small kidney tumors accessible by imaging, cryoablation involves percutaneous insertion of cryoprobes under CT or ultrasound guidance. The common practice is alternating freezing and thawing to form an ice ball covering the lesion, while monitoring adjacent structures. After the procedure, the probes are removed and pressure is applied for hemostasis. Postoperative observation focuses on bleeding, urine leakage, and pain, with the goal of ablating the lesion while preserving as much kidney tissue as possible. The above is general health information, not medical advice; specific details depend on specialist assessment and hospital protocols.

Including preoperative assessment, hospitalization, and post-discharge follow-up, a total of 1–2 weeks is recommended; subject to actual schedule and recovery.

Tell us about your Clear Cell Renal Carcinoma case and we will help match you with the right hospital, specialist, and travel pathway.